Puriolabs, LLC
Carrollton, TX Doing business as Puriolabs Puriolabs
- UEI
- LZWFPALEK7A4
- CAGE
- 917U3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1671 S Broadway St k12, Carrollton, TX 75006, USA
- Website
- puriolabs.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| DHA sequential phase II sbir puritall sterilizer - sequential phase II | Defense Health Agency | $1,946,974 | |
| DHA sbir phase II proposal H2-0728 titled: puritall mobile desktop device sterilizer - phase II | Defense Health Agency | $1,099,031 | |
| DHA 2021.3 sbir phase i medical r & d purchase order against proposal#H213-006-0066, titled: "puritall mobile desktop… | Medical Command | $249,277 |
About Puriolabs, LLC
Puriolabs, LLC is a small business limited liability company headquartered in Carrollton, Texas, that specializes in the research, development, and commercialization of innovative sterilization technologies for healthcare applications. The company has established itself as a participant in the federal Small Business Innovation Research (SBIR) program, leveraging government investment to advance medical device solutions that support the operational efficiency and healthcare delivery capabilities of federal agencies, particularly the Department of Defense's medical operations.
Puriolabs has secured three consecutive federal contract awards from the Defense Health Agency and Medical Command, all focused on the development and refinement of its proprietary Puritall Sterilizer technology. The company's federal contracting history began with a Phase I SBIR purchase order valued at $249,276.66 awarded on March 25, 2022, for the development of the Puritall Mobile Desktop Device Sterilizer. This initial phase was completed by October 24, 2022, demonstrating sufficient technical merit and commercial viability to warrant continuation. The company subsequently received a Phase II SBIR definitive contract on February 22, 2023, valued at $1,099,030.81, extending the period of performance through June 21, 2025, for continued development and prototype refinement of the mobile desktop device sterilizer. Most recently, Puriolabs secured a $1.95 million Phase II SBIR definitive contract awarded on September 5, 2025, by the Defense Health Agency for the Sequential Phase II Puritall Sterilizer project, with performance extending through January 4, 2028. All three awards carry total small business set-aside designations, confirming Puriolabs' status as a qualified small business concern and ensuring exclusive access to these federal opportunities. The progression from Phase I validation through multiple Phase II awards demonstrates the Defense Health Agency's confidence in the company's sterilization technology and its potential to enhance military medical facility operations.
Quick answers
What is Puriolabs, LLC's UEI?
Puriolabs, LLC's Unique Entity ID (UEI) in SAM.gov is LZWFPALEK7A4.
What is Puriolabs, LLC's CAGE code?
Puriolabs, LLC's CAGE code is 917U3.
What is Puriolabs, LLC's primary NAICS code?
Puriolabs, LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Puriolabs, LLC located?
Puriolabs, LLC's physical address in SAM.gov is 1671 S Broadway St k12, Carrollton, TX 75006, USA.
Is Puriolabs, LLC registered in SAM.gov?
Yes. Puriolabs, LLC's SAM.gov registration is active through July 31, 2027.
What is Puriolabs, LLC's most recent federal award?
Puriolabs, LLC's most recent federal contract award is DHA sequential phase II sbir puritall sterilizer - sequential phase II (HT942525CE015), from Defense Health Agency, on September 5, 2025.
On GovTribe
See Puriolabs, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors